Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study
The American Journal of Clinical Nutrition · 2025-03 · 121 (3) · 535-547
DOI: 10.1016/j.ajcnut.2025.01.006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The American Journal of Clinical Nutrition, 2025-03. Verfasst von Liangyu Yin und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Ur…. Hauptthemen laut MEDLINE: Cachexia, Machine Learning, Neoplasms, Body Weight. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, National Key Research and Development Program of China Stem Cell and Translational Research, Army Medical University.
Abstract (Originalsprache)
BACKGROUND: Cachexia is associated with multiple adverse outcomes in cancer. However, clinical decision-making for oncology patients at the cachexia stage presents significant challenges. OBJECTIVES: This study aims to develop a machine learning (ML) model to identify potentially reversible cancer cachexia (PRCC). METHODS: This was a multicenter cohort study. Cachexia was retrospectively diagnosed using Fearon's framework. PRCC was defined as a diagnosis of cancer cachexia at baseline that turned negative 1 mo later. Body weight dynamics accessible upon patient admission were screened and modeled to predict PRCC. Multiple ML models were trained and cross-validated using 70% of the data to predict PRCC, with the remaining 30% reserved for model evaluation. The interpretability and clinical usefulness of the optimal model were assessed, and external validation was performed in an independent cohort of 238 patients. RESULTS: The study enrolled 1983 men and 1784 women (median age = 58 y). PRCC was identified in 1983 patients (52.6%). Breast cancer exhibited the highest rate of PRCC (72.1%), whereas cachexia associated with various gastrointestinal cancers was less likely to be reversed. Weight change (WC) from 6 mo ago to 1 mo ago, WC from 1 mo ago to baseline (-1 to 0), and baseline body mass index were selected for modeling. A multilayer perceptron model showed good performance to predict PRCC in the holdout test set [area under the curve (95% confidence interval): 0.887 (0.866, 0.907); accuracy: 0.836; sensitivity: 0.859; specificity: 0.812] and the external validation set [area under the curve (95% confidence interval): 0.863 (0.778, 0.948)]. The WC -1 to 0 showed the highest impact on model output. The model was demonstrated to be clinically useful and statistically relevant. CONCLUSIONS: This study presents an explainable ML model for the early identification of PRCC that utilizes simple body weight dynamics. The findings showcase the potential of this approach in improving the management of cancer cachexia to optimize patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Milit…
- Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China.
- Department of Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China.
- Department of Integrated Chinese and Western Medicine, Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
- Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Förderung
- Natural Science Foundation of Chongqing Municipality
- National Key Research and Development Program of China Stem Cell and Translational Research
- Army Medical University
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yin, L., Li, N., Lin, X., Zhang, L., Fan, Y., Liu, J., Lu, Z., Li, W., Cui, J., Guo, Z., Yao, Q., Zhou, F., Liu, M., Chen, Z., Yu, H., Li, T., Li, Z., Jia, P., Song, C., …, & Xu, H. (2025). Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study. The American Journal of Clinical Nutrition, 121(3), 535-547. https://doi.org/10.1016/j.ajcnut.2025.01.006
Vancouver
Yin L, Li N, Lin X, Zhang L, Fan Y, Liu J, et al. Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study. The American Journal of Clinical Nutrition. 2025;121(3):535-547. doi:10.1016/j.ajcnut.2025.01.006
BibTeX
@article{Yin2025,
author = {Yin, Liangyu and Li, Na and Lin, Xin and Zhang, Ling and Fan, Yang and Liu, Jie and Lu, Zongliang and Li, Wei and Cui, Jiuwei and Guo, Zengqing and Yao, Qinghua and Zhou, Fuxiang and Liu, Ming and Chen, Zhikang and Yu, Huiqing and Li, Tao and Li, Zengning and Jia, Pingping and Song, Chunhua and Shi, Hanping and Xu, Hongxia},
title = {Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study},
journal = {The American Journal of Clinical Nutrition},
year = {2025},
volume = {121},
number = {3},
pages = {535--547},
doi = {10.1016/j.ajcnut.2025.01.006}
}
EUVIMED